SlideShare une entreprise Scribd logo
1  sur  73
Télécharger pour lire hors ligne
Trea%ng	
  Pain	
  

                  Dr.	
  Randy	
  Easterling	
  
                  MD,	
  The	
  Street	
  Clinic	
  
Medical	
  Director,	
  Marian	
  Hill	
  Chemical	
  Dependence	
  
                             Unit	
  	
  
                   Dr.	
  Daniel	
  Barne2	
  
Medical	
  Director,	
  BlueCross	
  BlueShield	
  Tennessee	
  
DISCLOSURE	
  STATEMENT	
  	
  
Randy	
  Easterling	
  has	
  no	
  financial	
  
rela%onships	
  with	
  proprietary	
  en%%es	
  that	
  
produce	
  health	
  care	
  goods	
  and	
  services.	
  	
  

Daniel	
  BarneD	
  has	
  no	
  financial	
  rela%onships	
  
with	
  proprietary	
  en%%es	
  that	
  produce	
  health	
  
care	
  goods	
  and	
  services.	
  	
  
 RANDY	
  EASTERLING,	
  MD	
  


•  DIPLOMAT	
  
     	
  AMERICAN	
  SOCIETY	
  OF	
  ADDICTION	
  MEDICINE	
  

•  MEDICAL	
  DIRECTOR	
  
    	
  MARION	
  HILL	
  CHEMICAL	
  DEPENDENCY	
  UNIT	
  
    	
  RIVER	
  REGION	
  HEALTH	
  SYSTEM,	
  VICKSBURG,	
  MS	
  

•  PRESIDENT	
  
  MISSISSIPPI	
  STATE	
  BOARD	
  OF	
  MEDICAL	
  LICENSURE	
  
TREATING	
  PAIN	
  



TODAY’S	
  SPEAKER	
  HAS	
  NO	
  DISCLOSURE	
  	
  
  TO	
  REPORT	
  OF	
  REAL	
  OR	
  APPARENT	
  	
  
        CONFLICT	
  RELATED	
  TO	
  THE	
  	
  
  CONTENT	
  OF	
  THIS	
  PRESENTATION.	
  	
  
CHRISTMAS	
  STORY	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  


•  	
  DRUG	
  OVERDOSED	
  DEATHS	
  INCREASED	
  	
  FOR	
  THE	
  
     11TH	
  CONSECUTIVE	
  YEAR	
  IN	
  2010.	
  	
  	
  

•  LEADING	
  DRUGS	
  RESPONSIBLE	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  FOR	
  
   FATALITIES	
  ARE	
  PRESCRIPTION	
  MEDS,	
  MOST	
  OF	
  
   WHICH	
  ARE	
  OPIOID	
  ANALGESICS.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  

•  THE	
  CENTERS	
  FOR	
  DISEASE	
  CONTROL	
  	
  	
  	
  	
  	
  AND	
  
   PREVENTION	
  FOUND	
  THAT	
  38,329	
  	
  	
  	
  	
  	
  DIED	
  FROM	
  
   DRUG	
  OVERDOSE	
  IN	
  2010.	
  

•  THAT’S	
  	
  UP	
  FROM	
  37,004	
  	
  
	
  	
  	
  DEATHS	
  IN	
  2009,	
  AND	
  	
  
	
  	
  	
  16,	
  849	
  DEATHS	
  IN	
  1999.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  

•  NEARLY	
  60%	
  OF	
  THE	
  OVERDOSE	
  DEATHS	
  IN	
  2010	
  
   INVOLVED	
  PHARMACEUTICAL	
  DRUGS.	
  

•  OPIOIDS	
  ACCOUNT	
  FOR	
  	
  
75%	
  OF	
  THESE	
  DEATHS.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  
•  	
  IN	
  2009	
  ACCIDENTAL	
  OPIOID	
  OVERDOSE	
  BECAME	
  THE	
  
   #1	
  LEADING	
  CAUSE	
  OF	
  ACCIDENTAL	
  DEATH	
  IN	
  THE	
  U.S.	
  




•  ACCIDENTAL	
  OVERDOSE	
  EXCEEDED	
  TRAFFIC	
  ACCIDENTS.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  
•  MORE	
  THAN	
  16,000	
  AMERICANS	
  DIED	
  	
  
	
  	
  	
  LAST	
  YEAR	
  IN	
  THE	
  UNITED	
  STATES	
  	
  
	
  	
  	
  FROM	
  ACCIDENTAL	
  OPIOID	
  OVERDOSE.	
  

•  U.S.	
  HAS	
  5%	
  OF	
  THE	
  	
  
	
  	
  	
  WORLD	
  POPULATION.	
  	
  

•  USE	
  99%	
  OF	
  THE	
  	
  
	
  	
  	
  HYDROCODONE	
  	
  
	
  	
  	
  PRODUCED	
  IN	
  THE	
  WORLD.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  

•  ENOUGH	
  HYDROCODONE	
  WRITTEN	
  EACH	
  YEAR	
  
   IN	
  THE	
  U.S.	
  TO	
  GIVE	
  EVERY	
  MAN,	
  WOMAN,	
  AND	
  
   CHILD	
  IN	
  THIS	
  COUNTRY	
  5	
  MG	
  EVERY	
  4	
  HOURS	
  
   FOR	
  30	
  DAYS.	
  

•  111	
  TONS	
  WERE	
  DISPENSED	
  IN	
  2010:	
  
      	
  69	
  TONS	
  OF	
  PURE	
  OXYCODONE	
  
      	
  42	
  TONS	
  OF	
  PURE	
  HYDROCODONE	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  

•  IF	
  YOU	
  GIVE	
  A	
  PATIENT	
  	
  
	
  	
  	
  HYDROCODONE	
  	
  FOR	
  90	
  DAYS	
  –	
  	
  
	
  	
  	
  REGARDLESS	
  OF	
  THE	
  REASON	
  …...	
  

•  66%	
  OF	
  THOSE	
  PATIENTS	
  WILL	
  	
  
	
  	
  	
  BE	
  TAKING	
  	
  HYDROCODONE	
  	
  
	
  	
  	
  DAILY	
  5	
  YEARS	
  LATER.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  

•  VICODAN	
  IS	
  NOW	
  THE	
  MOST	
  WIDELY	
  
             PRESCRIBED	
  MEDICATION	
  	
  
	
  	
  	
  IN	
  THE	
  UNITED	
  STATES	
  …	
  

•  FOLLOWED	
  BY	
  	
  
	
  	
  	
  LISINOPRIL	
  …	
  

•  THEN,	
  ZOCOR.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  

•  7	
  MILLION	
  AMERICANS	
  	
  	
  
	
  	
  	
  ADDICTED	
  TO	
  PRESCRIPTION	
  	
  
	
  	
  	
  OPIOIDS	
  IN	
  THE	
  U.S.	
  

•  TAKING	
  PRESCRIPTION	
  	
  
	
  	
  	
  PAIN	
  KILLERS	
  WITHOUT	
  	
  
	
  	
  	
  MEDICAL	
  NEED	
  	
  
	
  	
  	
  INCREASED	
  75%	
  	
  
	
  	
  	
  FROM	
  2002	
  TO	
  2010.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  

•  	
  IN	
  2010,	
  12	
  MILLION	
  AMERICANS	
  	
  
	
  	
  	
  	
  AGE	
  12	
  AND	
  OLDER	
  REPORTED	
  	
  
	
  	
  	
  	
  NON-­‐MEDICAL	
  USE	
  OF	
  PRESCRIPTION	
  	
  
	
  	
  	
  	
  PAIN	
  KILLERS	
  IN	
  THE	
  PAST	
  YEAR.	
  

•  NEARLY	
  ½	
  MILLION	
  EMERGENCY	
  DEPARTMENT	
  
             VISITS	
  IN	
  2009	
  WERE	
  	
  
	
  	
  	
  DUE	
  TO	
  PEOPLE	
  MIS-­‐USING	
  OR	
  ABUSING	
  	
  	
  	
  	
  	
  
	
  	
  	
  PRESCRIPTION	
  PAIN	
  KILLERS.	
  
WHY	
  ALL	
  THE	
  FUSS	
  ?	
  

•  NON-­‐MEDICAL	
  USE	
  OF	
  	
  
	
  	
  	
  PRESCRIPTION	
  PAIN	
  KILLERS	
  
	
  	
  	
  COSTS	
  HEALTH	
  INSURORS	
  UP	
  	
  
	
  	
  	
  TO	
  $72.5	
  BILLION	
  ANNUALLY	
  	
  
	
  	
  	
  FOR	
  DIRECT	
  HEALTH	
  CARE.	
  	
  

•  	
  98	
  OF	
  THE	
  TOP	
  100	
  DOCTORS	
  	
  
	
  	
  	
  	
  IN	
  THE	
  COUNTRY	
  DISPENSING	
  OXYCODONE	
  	
  	
  	
  
	
  	
  	
  	
  DO	
  SO	
  IN	
  THE	
  STATE	
  OF	
  FLORIDA.	
  
 NEONATAL	
  ABSTINENCE	
  SYNDROME	
  
HOW	
  DID	
  WE	
  GET	
  HERE	
  FROM	
  
                        THERE	
  ?	
  
•  EVOLVED	
  INTO	
  A	
  SOCIETY	
  THAT	
  BELIEVES	
  WE	
  
            ARE	
  SUPPOSED	
  	
  
	
  	
  	
  TO	
  FEEL	
  GOOD	
  ALL	
  THE	
  TIME.	
  

•  PAIN	
  AND	
  	
  
	
  	
  	
  DISCOMFORT	
  	
  
	
  	
  	
  ARE	
  BAD.	
  
CHEMICAL	
  COPING	
  

•  PHYSICIANS	
  	
  
	
  	
  ARE	
  	
  EXPECTED	
  	
  	
  
	
  	
  TO	
  ALLEVIATE	
  ALL	
  	
  	
  	
  	
  	
  
	
  	
  UNPLEASANTNESS.	
  	
  	
  
•  PRESCRIPTION	
  OPIOIDS	
  ARE	
  
         PLENTIFUL	
  	
  
	
  	
  AND	
  VERY	
  	
  
	
  	
  INEXPENSIVE.	
  
STREET	
  PRICES	
  


– 10	
  MG	
  HYDROCODONE	
  	
  …	
  $6	
  -­‐	
  $8.	
  

– OXYCODONE	
  …	
  $10	
  -­‐	
  $20	
  

– 4	
  MG	
  DILAUDID	
  …	
  $60	
  

– ADDERALL	
  …	
  $1	
  MG	
  	
  
STREET	
  PRICES	
  

– BENZODIAZEPINE	
  $1	
  -­‐	
  $2	
  MG	
  

– RITALIN	
  $10	
  -­‐	
  	
  $20	
  

– SOMA	
  $3	
  
MOBILITY	
  

•  HIT	
  2	
  OR	
  3	
  DOCTORS	
  OFFICES	
  
   PLUS	
  SEVERAL	
  EMERGENCY	
  
   ROOMS	
  IN	
  12	
  HOURS.	
  
A	
  BEAST	
  THAT	
  CAN’T	
  BE	
  FED	
  

	
  	
  	
  	
  THERE	
  IS	
  A	
  NEVER	
  
	
  	
  	
  ENDING	
  NEED	
  	
  
	
  	
  	
  FOR	
  THE	
  DRUG.	
  	
  	
  
HOLY	
  TRINITY	
  

•  HYDROCODONE	
  IS	
  EASILY	
  COMBINED	
  	
  
	
  	
  	
  WITH	
  OTHER	
  MOOD-­‐ALTERING	
  DRUGS.	
  

•  HYDROCODONE,	
  	
  
	
  	
  	
  XANAX	
  AND	
  SOMA	
  	
  
	
  	
  	
  ARE	
  THE	
  HOLY	
  TRINITY.	
  	
  	
  
DRUG	
  OF	
  CHOICE	
  




ADD	
  A	
  LITTLE	
  BIT	
  OF	
  JACK	
  	
  
DANIELS	
  AND	
  YOU	
  HAVE	
  	
  
THE	
  WHITNEY	
  HOUSTON	
  COCKTAIL.	
  	
  	
  
LAW	
  ENFORCEMENT	
  

•  VERY	
  DIFFICULT	
  TO	
  STAY	
  ON	
  	
  
	
  	
  	
  TOP	
  OF	
  THIS	
  EPIDEMIC.	
  	
  	
  

•  LAW	
  ENFORCEMENT	
  IS	
  OUT-­‐NUMBERED	
  AND	
  
   OUT-­‐FINANCED.	
  
LAW	
  ENFORCEMENT	
  


•  DRUG	
  DEALERS	
  USUALLY	
  
	
  	
  	
  DO	
  NOT	
  SUFFER	
  FROM	
  	
  
	
  	
  	
  THE	
  SAME	
  BUDGET	
  	
  
	
  	
  	
  CONTRAINTS	
  AS	
  LAW	
  ENFORCEMENT.	
  	
  	
  

•  CANNOT	
  “ARREST	
  OUR	
  WAY	
  OUT	
  OF	
  THIS	
  
   PROBLEM.”	
  
EPIDEMIC	
  PROPORTIONS	
  

•  THIS	
  EPIDEMIC	
  HAS	
  ENGULFED	
  OUR	
  
        COUNTRY,	
  OUR	
  PRACTICES,	
  OUR	
  SOCIETY,	
  
        AND	
  	
  
	
  	
  OUR	
  LIVELIHOODS.	
  	
  	
  
REAL	
  ESTATE	
  STORY	
  
PHYSICIAN	
  PROFILE	
  

QUESTION:	
  
•  WHAT	
  TYPE	
  OF	
  DOCTOR	
  	
  
	
  	
  	
  PRESCRIBES	
  EXCESSIVE	
  	
  
	
  	
  	
  AMOUNTS	
  OF	
  OPIOIDS?	
  

ANSWER:	
  
•  GOOD	
  CLINICIAN	
  
PHYSICIAN	
  PROFILE	
  

•  TYPICALLY,	
  WELL	
  TRAINED	
  PAIN	
  
   MANAGEMENT	
  PHYSICIANS.	
  	
  	
  


•  PROCEDURELESS	
  	
  


•  OFTEN	
  WRITE	
  	
  
	
  	
  LARGE	
  VOLUMES	
  OF	
  PAIN	
  MEDICATION.	
  
PHYSICIAN	
  PROFILE	
  
•  WELL-­‐INTENTIONED	
  PHYSICIANS	
  WHO	
  BELIEVE	
  PEOPLE	
  ARE	
  
   NOT	
  SUPPOSED	
  TO	
  HURT.	
  	
  	
  

•  DO	
  NOT	
  PRACTICE	
  	
  
	
  	
  	
  EVIDENCE	
  BASED	
  	
  
	
  	
  	
  MEDICINE.	
  	
  	
  

•  WRITE	
  LARGE	
  	
  
	
  	
  	
  QUANTITIES	
  OF	
  	
  
	
  	
  	
  OPIOIDS	
  WITH	
  REFILLS.	
  	
  
CHEMICAL	
  COPING	
  

TYPICAL	
  PRESCRIPTION:	
  

•  LORCET	
  PLUS	
  #90	
  OR	
  #120	
  	
  
•  ONE	
  P.O.	
  T.I.D.	
  OR	
  …	
  
•  ONE	
  P.O.	
  Q.I.D.	
  WITH	
  5	
  REFILLS.	
  	
  	
  
WHEN	
  MONEY	
  DRIVES	
  MEDICINE	
  

•  CRIMINALS	
  WITH	
  A	
  MEDICAL	
  DEGEREE	
  AND	
  
   LICENSE	
  TO	
  PRACTICE	
  MEDICINE	
  

•  STATE	
  BOARD	
  OF	
  	
  
	
  	
  	
  MEDICAL	
  LICENSURE	
  

•  SMALL	
  COHORT	
  	
  
	
  	
  OF	
  PHYSICIANS	
  
MONITORING	
  PRESCRIBING	
  PATTERNS	
  


•  HOW	
  DO	
  YOU	
  IDENTIFY	
  	
  
	
  	
  	
  PHYSICIANS	
  WHO	
  WRITE	
  	
  
	
  	
  	
  TOO	
  MANY	
  OPIOIDS?	
  
MONITORING	
  PRESCRIBING	
  PATTERNS	
  
PHARMACISTS	
  	
  

•  EXCELLENT	
  SOURCE	
  OF	
  INFORMATION.	
  	
  	
  

•  KNOW	
  WHICH	
  DOCTORS	
  HAVE	
  A	
  LOOSE	
  PEN.	
  	
  	
  

•  KNOW	
  THE	
  PRESCRIBING	
  HABITS	
  OF	
  EACH	
  PROVIDER	
  
   IN	
  THEIR	
  COMMUNITY.	
  	
  	
  
PRESCRIPTION	
  MONITORING	
  PROGRAM	
  


•  CAN	
  BE	
  RUN	
  ON	
  INDIVIDUAL	
  PATIENTS	
  AND	
  
   INDIVIDUAL	
  PRESCRIBERS.	
  

•  EXCELLENT	
  TOOL	
  FOR	
  IDENTIFYING	
  DRUG	
  
   SEEKING	
  PATIENTS	
  AND	
  PRESCRIBERS	
  WHO	
  
   WRITE	
  TOO	
  MANY	
  SCHEDULED	
  DRUGS.	
  	
  	
  
PRESCRIPTION	
  MONITORING	
  
             PROGRAM	
  

DRAWBACKS	
  

       – NOT	
  REAL	
  TIME	
  
       – NOT	
  INTERSTATE	
  
       – LACK	
  OF	
  FUNDING	
  
• TAG	
  CHECK	
  	
  

• ZIP	
  CODE	
  CHECK	
  	
  
PHYSICIAN	
  DRIFT	
  

•  OUT-­‐OF-­‐SPECIALTLY	
  	
  
	
  	
  	
  PHYSICIANS	
  	
  
	
  	
  	
  PRACTICING	
  	
  
	
  	
  	
  IN	
  PAIN	
  CLINICS	
  	
  	
  
BUSINESS	
  OF	
  MEDICINE	
  

•  PAIN	
  CLINICS	
  OWNED	
  BY	
  NON-­‐PHYSICIANS	
  AS	
  
   BUSINESS	
  VENTURES.	
  	
  	
  

•  EMPLOY	
  	
  
	
  	
  	
  PHYSICIANS	
  	
  

•  CASH	
  ONLY	
  	
  
	
  	
  	
  PILL	
  MILLS	
  
•  RETIRED	
  OR	
  OLDER	
  PHYSICIAN.	
  	
  	
  

•  LIKES	
  PRACTICING	
  MEDICINE	
  AGAIN.	
  	
  	
  

•  RESIDENTS	
  	
  
	
  	
  	
  WHO	
  MOONLIGHT.	
  	
  

•  PRESCRIPTIVE	
  	
  
	
  	
  	
  PATTERN	
  THAT	
  IS	
  	
  
	
  	
  	
  OUT	
  OF	
  THE	
  ORDINARY	
  
NEW	
  CME	
  REQUIREMENT	
  	
  

•  EVERY	
  LICENSEE	
  	
  
•  40	
  HOURS	
  	
  
	
  	
  	
  IN	
  A	
  2-­‐YEAR	
  CYCLE	
  	
  
•  5	
  HOURS	
  RELATED	
  	
  
	
  	
  	
  TO	
  “PRESCRIBING	
  	
  
	
  	
  	
  MEDICATIONS”	
  
•  EMPHASIS	
  ON	
  	
  
	
  	
  	
  CONTROLLED	
  SUBSTANCES.	
  	
  	
  
THE	
  SCIENCE	
  OF	
  OPOIDS	
  


•  PROVEN	
  EFFICACY	
  FOR	
  USE	
  OF	
  OPIOIDS	
  	
  
	
  	
  	
  FOR	
  SHORT	
  TERM	
  NON-­‐CANCER	
  PAIN.	
  	
  	
  

•  VERY	
  LITTLE	
  SCIENTIFIC	
  EVIDENCE	
  THAT	
  
   LONGTERM	
  USE	
  OF	
  OPIOIDS	
  FOR	
  NON-­‐
   CANCER	
  PAIN	
  IS	
  EFFECTIVE.	
  	
  	
  
THE	
  SCIENCE	
  OF	
  OPOIDS	
  

•  SIGNIFICANT	
  EVIDENCE	
  THAT	
  LONG	
  TERM	
  OPIOID	
  
             USE	
  FOR	
  NON-­‐CANCER	
  PAIN	
  WILL	
  RESULT	
  IN	
  OPIOID	
  	
  
	
  	
  	
  HYPERALYGESIA	
  	
  
	
  	
  	
  SYNDROME.	
  
QUESTIONS	
  ?	
  


•  ANSWERS	
  …	
  $5	
  

•  CORRECT	
  ANSWERS	
  	
  …	
  $10	
  

•  CORRECT	
  ANSWERS	
  	
  
	
  	
  YOU	
  CAN	
  UNDERSTAND	
  	
  …	
  $25	
  	
  
TREATING	
  PAIN	
  
  Randy	
  Easterling,	
  M.D.	
  
  Dan	
  BarneD,	
  M.D.,	
  J.D.	
  
         April	
  2,	
  2013	
  
Disclosures	
  
Daniel	
  BarneD	
  has	
  no	
  financial	
  rela%onships	
  with	
  proprietary	
  
  en%%es	
  that	
  produce	
  health	
  care	
  goods	
  and	
  services.	
  
Where	
  Tennessee	
  Stands	
  

•  2nd	
  Most	
  Medicated	
  State	
  (Forbes	
  
   Magazine,	
  August	
  16,	
  2010)	
  

•  5th	
  in	
  Average	
  Mg.	
  Opioids/Resident	
  (Oct.	
  
   2012	
  Journal	
  of	
  Pain)	
  
Controlled	
  Substances	
  in	
  Tennessee	
  
•  Just	
  over	
  18	
  million	
  prescrip%ons	
  for	
  
   controlled	
  substances	
  dispensed	
  in	
  2012.	
  

•  Increase	
  of	
  1.5	
  %	
  from	
  2011	
  (compared	
  to	
  a	
  
   23%	
  rise	
  from	
  2010	
  –	
  2011).	
  

•  Increased	
  use	
  of	
  TN	
  Controlled	
  Substance	
  
   Database/State	
  Registra%on	
  of	
  Pain	
  Clinics.	
  
The	
  Source	
  
Issue:	
  How	
  to	
  Control	
  the	
  Source	
  of	
  
              Controlled	
  Substances?	
  

•  Solu%on:	
  	
  Oversight	
  of	
  the	
  Prescribing	
  
   Physicians.	
  

•  But	
  How?	
  
Physicians	
  
1.  Highly	
  Educated	
  

2.  Lengthy	
  Training	
  

3.  Ongoing	
  CME	
  Requirements	
  

4.  Independent	
  
PEER	
  REVIEW	
  
•  Other	
  Physicians	
  Reviewing	
  the	
  Records	
  
   and	
  Management	
  of	
  Physicians	
  with	
  
   Possible	
  Quality	
  Problems	
  
•  Used	
  in	
  Hospitals	
  for	
  years	
  
•  Why	
  not	
  in	
  Health	
  Plans?	
  
PLANS	
  ARE	
  IN	
  A	
  GOOD	
  POSITION	
  TO	
  
     ASSESS	
  QUALITY	
  OF	
  CARE	
  OF	
  NETWORK	
  
                       PROVIDERS	
  
•    We	
  pay	
  claims	
  (and	
  have	
  claims	
  data).	
  
•    We	
  have	
  audit	
  rights	
  in	
  provider	
  contracts.	
  
•    We	
  review	
  medical	
  records.	
  
•    We	
  are	
  in	
  providers’	
  offices.	
  
•    No	
  “compe%tors	
  out	
  to	
  get	
  me”	
  in	
  Plan	
  peer	
  review.	
  
Health	
  Plans?	
  
The	
  BCBST	
  CRM	
  Program	
  Reviews	
  All	
  
  Quality	
  of	
  Care	
  Complaints	
  and	
  Concerns	
  

•  Required	
  to	
  review	
  member	
  complaints	
  
   by	
  accredi%ng	
  agencies	
  (NCQA,	
  URAC)	
  
   and	
  state	
  Medicaid	
  program.	
  

•  Liability/Risk	
  reduc%on	
  method.	
  
The	
  BCBST	
  CRM	
  Program	
  is	
  staffed	
  by	
  
           clinical	
  professionals	
  
•  4	
  RNs	
  review	
  cases.	
  

•  Support	
  from	
  BCBST	
  Pharmacy	
  Department	
  
   staffed	
  by	
  12	
  Pharmacists.	
  

•  Support	
  from	
  Analy%cs	
  Area	
  to	
  Review	
  
   Prescribing	
  Data.	
  
How	
  Do	
  We	
  Get	
  RX	
  Cases?	
  
•  Referrals	
  from	
  Pharmacy	
  Department.	
  

•  Pharmacists	
  iden%fy	
  outliers	
  in	
  their	
  areas	
  of	
  
   responsibility	
  and	
  contact	
  the	
  providers	
  to	
  try	
  
   to	
  determine	
  why	
  they	
  are	
  outliers.	
  

•  If	
  no	
  explana%on	
  and	
  no	
  change	
  in	
  prac%ce	
  
   aser	
  contact,	
  refer	
  to	
  CRM.	
  
Also	
  from	
  Member	
  Complaints	
  
	
  	
  	
  	
  Mbr	
  wants	
  complaint	
  filed	
  against	
  provider	
  
                (prv).	
  On	
  one	
  visit,	
  mbr	
  didn’t	
  want	
  his	
  shot	
  b/c	
  
                they	
  were	
  administering	
  it	
  where	
  it	
  was	
  making	
  
                mbr's	
  back	
  swell	
  up.	
  Aser	
  he	
  declined	
  the	
  shot,	
  
                the	
  prv	
  ripped	
  up	
  his	
  rx	
  for	
  Valium.	
  Once	
  the	
  rx	
  
                was	
  ripped	
  up,	
  mbr	
  had	
  no	
  choice	
  but	
  to	
  take	
  
                the	
  shot.	
  Then	
  aser	
  they	
  gave	
  him	
  the	
  shot,	
  
                they	
  rewrote	
  his	
  rx	
  for	
  Valium.	
  Per	
  mbr,	
  it	
  was	
  
                as	
  if	
  prv	
  was	
  blackmailing	
  him:	
  if	
  he	
  didn’t	
  take	
  
                the	
  shot,	
  they	
  wouldn’t	
  write	
  his	
  rx.	
  	
  
The	
  CRM	
  Process	
  
1.  Obtain	
  medical	
  records	
  from	
  dates	
  of	
  service	
  
    when	
  pain	
  meds.	
  prescribed.	
  

2.  Review	
  medical	
  records	
  internally.	
  

3.  Refer	
  suspect	
  records	
  for	
  specialty	
  matched	
  
    review	
  (through	
  Independent	
  Review	
  
    Organiza%ons).	
  
Standard	
  of	
  Care	
  

That	
  level	
  of	
  care	
  below	
  which	
  no	
  	
  
reasonable	
  medical	
  provider	
  would	
  
	
  prac%ce.	
  
Medical	
  Correc%ve	
  Ac%on	
  Plan	
  
•  Specialty	
  matched	
  review	
  shows	
  
   standard	
  of	
  care	
  not	
  met	
  for	
  controlled	
  
   substance	
  prescribing.	
  
•  LeDer	
  with	
  reviewer’s	
  comments	
  giving	
  
   examples	
  of	
  why	
  standard	
  not	
  met.	
  
•  Provider	
  advised	
  to	
  take	
  whatever	
  steps	
  
   are	
  necessary	
  to	
  correct	
  prac%ce.	
  
Model	
  Policy	
  for	
  the	
  Use	
  of	
  Controlled	
  
                Substances	
  for	
  the	
  Treatment	
  of	
  Pain	
  
Medical	
  Records	
  –	
  The	
  physician	
  should	
  keep	
  accurate	
  and	
  complete	
  records	
  to	
  include:	
  

   1.  the	
  medical	
  history	
  and	
  physical	
  examina%on,	
  
   2.  diagnos%c,	
  therapeu%c	
  and	
  laboratory	
  results,	
  
   3.  evalua%ons	
  and	
  consulta%ons,	
  	
  
   4.  treatment	
  objec%ves,	
  
   5.  decision	
  of	
  risks	
  and	
  benefits,	
  	
  
   6.  informed	
  consent,	
  	
  
   7.  treatments,	
  
   8.  medica%ons	
  (including	
  date,	
  type,	
  dosage	
  and	
  quan%ty	
  prescribed),	
  
   9.  instruc%ons	
  and	
  agreements	
  and	
  
   10.  periodic	
  reviews.	
  

Records	
  should	
  remain	
  current	
  and	
  be	
  maintained	
  in	
  an	
  accessible	
  	
  
manner	
  and	
  readily	
  available	
  for	
  review.	
  
Reasons	
  for	
  MCAP	
  Failure	
  

1.  	
  	
  	
  	
  Lack	
  of	
  Provider	
  Knowledge	
  


2. 	
  TIME	
  	
  =	
  	
  MONEY	
  
Consequences	
  of	
  MCAP	
  Failure	
  
1.  Creden%aling	
  CommiDee	
  –	
  Creden%als	
  
    Revoked.	
  
2.  Formal	
  Hearing	
  –	
  Due	
  Process	
  
3.  Report	
  Filed	
  with	
  Healthcare	
  Integrity	
  
    and	
  Protec%on	
  Data	
  Bank	
  (HIPDB)	
  
QUESTIONS	
  


     ?	
  

Contenu connexe

Similaire à Treating pain final_rev

Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency DepartmentTackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency DepartmentSCGH ED CME
 
5th Annual Early Age Onset Colorectal Cancer - Session V: Part I
5th Annual Early Age Onset Colorectal Cancer - Session V: Part I 5th Annual Early Age Onset Colorectal Cancer - Session V: Part I
5th Annual Early Age Onset Colorectal Cancer - Session V: Part I Colon Cancer Challenge Foundation
 
Violence Against Doctors Panel Discussion on 6/07/2018
Violence Against Doctors  Panel Discussion on 6/07/2018Violence Against Doctors  Panel Discussion on 6/07/2018
Violence Against Doctors Panel Discussion on 6/07/2018Niranjan Chavan
 
Dfu and nsti
Dfu and nstiDfu and nsti
Dfu and nstiZamari
 
Supersize me
Supersize meSupersize me
Supersize medetjen
 
Management of Schizophrenia (Dr.Subrata Naskar)
Management of Schizophrenia (Dr.Subrata Naskar)Management of Schizophrenia (Dr.Subrata Naskar)
Management of Schizophrenia (Dr.Subrata Naskar)Subrata Naskar
 
How We Do Harm: A Webinar by SHARE with Dr. Otis Brawley
How We Do Harm: A Webinar by SHARE with Dr. Otis BrawleyHow We Do Harm: A Webinar by SHARE with Dr. Otis Brawley
How We Do Harm: A Webinar by SHARE with Dr. Otis Brawleybkling
 
Spectrum of health & Iceberg Phenomenon of disease.pptx
Spectrum of health & Iceberg Phenomenon of disease.pptxSpectrum of health & Iceberg Phenomenon of disease.pptx
Spectrum of health & Iceberg Phenomenon of disease.pptxDrSindhuAlmas
 
Americans patients exposed to counterfeit and black market medication
Americans patients exposed to counterfeit and black market medicationAmericans patients exposed to counterfeit and black market medication
Americans patients exposed to counterfeit and black market medicationThe Partnership For Safe Medicines
 
The American prescription opioid crisis
The American prescription opioid crisisThe American prescription opioid crisis
The American prescription opioid crisisscanFOAM
 
PSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient Safety
PSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient SafetyPSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient Safety
PSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient SafetyThe Partnership For Safe Medicines
 
Living as Well as you Can for As Long as you Can
Living as Well as you Can for As Long as you CanLiving as Well as you Can for As Long as you Can
Living as Well as you Can for As Long as you CanBCCPA
 
Lisa Girion: "Reporting on America’s Opioid Drug Crisis" 4.11.17
Lisa Girion: "Reporting on America’s Opioid Drug Crisis" 4.11.17Lisa Girion: "Reporting on America’s Opioid Drug Crisis" 4.11.17
Lisa Girion: "Reporting on America’s Opioid Drug Crisis" 4.11.17reportingonhealth
 
understanding-Opioid-Crisis-using-decision-heuristics-science.pdf
understanding-Opioid-Crisis-using-decision-heuristics-science.pdfunderstanding-Opioid-Crisis-using-decision-heuristics-science.pdf
understanding-Opioid-Crisis-using-decision-heuristics-science.pdfNewristics USA
 
Janes Presentation
Janes PresentationJanes Presentation
Janes Presentationjane Ogbonna
 

Similaire à Treating pain final_rev (20)

Us H&F
Us H&FUs H&F
Us H&F
 
Onychomycosis and diabetes
Onychomycosis and diabetesOnychomycosis and diabetes
Onychomycosis and diabetes
 
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency DepartmentTackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
 
5th Annual Early Age Onset Colorectal Cancer - Session V: Part I
5th Annual Early Age Onset Colorectal Cancer - Session V: Part I 5th Annual Early Age Onset Colorectal Cancer - Session V: Part I
5th Annual Early Age Onset Colorectal Cancer - Session V: Part I
 
Violence Against Doctors Panel Discussion on 6/07/2018
Violence Against Doctors  Panel Discussion on 6/07/2018Violence Against Doctors  Panel Discussion on 6/07/2018
Violence Against Doctors Panel Discussion on 6/07/2018
 
2012 Health Law Seminar
2012 Health Law Seminar2012 Health Law Seminar
2012 Health Law Seminar
 
Dfu and nsti
Dfu and nstiDfu and nsti
Dfu and nsti
 
Supersize me
Supersize meSupersize me
Supersize me
 
Management of Schizophrenia (Dr.Subrata Naskar)
Management of Schizophrenia (Dr.Subrata Naskar)Management of Schizophrenia (Dr.Subrata Naskar)
Management of Schizophrenia (Dr.Subrata Naskar)
 
How We Do Harm: A Webinar by SHARE with Dr. Otis Brawley
How We Do Harm: A Webinar by SHARE with Dr. Otis BrawleyHow We Do Harm: A Webinar by SHARE with Dr. Otis Brawley
How We Do Harm: A Webinar by SHARE with Dr. Otis Brawley
 
Spectrum of health & Iceberg Phenomenon of disease.pptx
Spectrum of health & Iceberg Phenomenon of disease.pptxSpectrum of health & Iceberg Phenomenon of disease.pptx
Spectrum of health & Iceberg Phenomenon of disease.pptx
 
Americans patients exposed to counterfeit and black market medication
Americans patients exposed to counterfeit and black market medicationAmericans patients exposed to counterfeit and black market medication
Americans patients exposed to counterfeit and black market medication
 
The American prescription opioid crisis
The American prescription opioid crisisThe American prescription opioid crisis
The American prescription opioid crisis
 
PSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient Safety
PSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient SafetyPSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient Safety
PSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient Safety
 
Living as Well as you Can for As Long as you Can
Living as Well as you Can for As Long as you CanLiving as Well as you Can for As Long as you Can
Living as Well as you Can for As Long as you Can
 
Lisa Girion: "Reporting on America’s Opioid Drug Crisis" 4.11.17
Lisa Girion: "Reporting on America’s Opioid Drug Crisis" 4.11.17Lisa Girion: "Reporting on America’s Opioid Drug Crisis" 4.11.17
Lisa Girion: "Reporting on America’s Opioid Drug Crisis" 4.11.17
 
Epidemiology and Opioids
Epidemiology and OpioidsEpidemiology and Opioids
Epidemiology and Opioids
 
understanding-Opioid-Crisis-using-decision-heuristics-science.pdf
understanding-Opioid-Crisis-using-decision-heuristics-science.pdfunderstanding-Opioid-Crisis-using-decision-heuristics-science.pdf
understanding-Opioid-Crisis-using-decision-heuristics-science.pdf
 
Opioid-Epidemic.pdf
Opioid-Epidemic.pdfOpioid-Epidemic.pdf
Opioid-Epidemic.pdf
 
Janes Presentation
Janes PresentationJanes Presentation
Janes Presentation
 

Plus de OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 

Plus de OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 

Treating pain final_rev

  • 1. Trea%ng  Pain   Dr.  Randy  Easterling   MD,  The  Street  Clinic   Medical  Director,  Marian  Hill  Chemical  Dependence   Unit     Dr.  Daniel  Barne2   Medical  Director,  BlueCross  BlueShield  Tennessee  
  • 2. DISCLOSURE  STATEMENT     Randy  Easterling  has  no  financial   rela%onships  with  proprietary  en%%es  that   produce  health  care  goods  and  services.     Daniel  BarneD  has  no  financial  rela%onships   with  proprietary  en%%es  that  produce  health   care  goods  and  services.    
  • 3.  RANDY  EASTERLING,  MD   •  DIPLOMAT    AMERICAN  SOCIETY  OF  ADDICTION  MEDICINE   •  MEDICAL  DIRECTOR    MARION  HILL  CHEMICAL  DEPENDENCY  UNIT    RIVER  REGION  HEALTH  SYSTEM,  VICKSBURG,  MS   •  PRESIDENT   MISSISSIPPI  STATE  BOARD  OF  MEDICAL  LICENSURE  
  • 4. TREATING  PAIN   TODAY’S  SPEAKER  HAS  NO  DISCLOSURE     TO  REPORT  OF  REAL  OR  APPARENT     CONFLICT  RELATED  TO  THE     CONTENT  OF  THIS  PRESENTATION.    
  • 6. WHY  ALL  THE  FUSS  ?   •   DRUG  OVERDOSED  DEATHS  INCREASED    FOR  THE   11TH  CONSECUTIVE  YEAR  IN  2010.       •  LEADING  DRUGS  RESPONSIBLE                                    FOR   FATALITIES  ARE  PRESCRIPTION  MEDS,  MOST  OF   WHICH  ARE  OPIOID  ANALGESICS.  
  • 7. WHY  ALL  THE  FUSS  ?   •  THE  CENTERS  FOR  DISEASE  CONTROL            AND   PREVENTION  FOUND  THAT  38,329            DIED  FROM   DRUG  OVERDOSE  IN  2010.   •  THAT’S    UP  FROM  37,004          DEATHS  IN  2009,  AND          16,  849  DEATHS  IN  1999.  
  • 8. WHY  ALL  THE  FUSS  ?   •  NEARLY  60%  OF  THE  OVERDOSE  DEATHS  IN  2010   INVOLVED  PHARMACEUTICAL  DRUGS.   •  OPIOIDS  ACCOUNT  FOR     75%  OF  THESE  DEATHS.  
  • 9. WHY  ALL  THE  FUSS  ?   •   IN  2009  ACCIDENTAL  OPIOID  OVERDOSE  BECAME  THE   #1  LEADING  CAUSE  OF  ACCIDENTAL  DEATH  IN  THE  U.S.   •  ACCIDENTAL  OVERDOSE  EXCEEDED  TRAFFIC  ACCIDENTS.  
  • 10. WHY  ALL  THE  FUSS  ?   •  MORE  THAN  16,000  AMERICANS  DIED          LAST  YEAR  IN  THE  UNITED  STATES          FROM  ACCIDENTAL  OPIOID  OVERDOSE.   •  U.S.  HAS  5%  OF  THE          WORLD  POPULATION.     •  USE  99%  OF  THE          HYDROCODONE          PRODUCED  IN  THE  WORLD.  
  • 11. WHY  ALL  THE  FUSS  ?   •  ENOUGH  HYDROCODONE  WRITTEN  EACH  YEAR   IN  THE  U.S.  TO  GIVE  EVERY  MAN,  WOMAN,  AND   CHILD  IN  THIS  COUNTRY  5  MG  EVERY  4  HOURS   FOR  30  DAYS.   •  111  TONS  WERE  DISPENSED  IN  2010:    69  TONS  OF  PURE  OXYCODONE    42  TONS  OF  PURE  HYDROCODONE  
  • 12. WHY  ALL  THE  FUSS  ?   •  IF  YOU  GIVE  A  PATIENT          HYDROCODONE    FOR  90  DAYS  –          REGARDLESS  OF  THE  REASON  …...   •  66%  OF  THOSE  PATIENTS  WILL          BE  TAKING    HYDROCODONE          DAILY  5  YEARS  LATER.  
  • 13. WHY  ALL  THE  FUSS  ?   •  VICODAN  IS  NOW  THE  MOST  WIDELY   PRESCRIBED  MEDICATION          IN  THE  UNITED  STATES  …   •  FOLLOWED  BY          LISINOPRIL  …   •  THEN,  ZOCOR.  
  • 14. WHY  ALL  THE  FUSS  ?   •  7  MILLION  AMERICANS            ADDICTED  TO  PRESCRIPTION          OPIOIDS  IN  THE  U.S.   •  TAKING  PRESCRIPTION          PAIN  KILLERS  WITHOUT          MEDICAL  NEED          INCREASED  75%          FROM  2002  TO  2010.  
  • 15. WHY  ALL  THE  FUSS  ?   •   IN  2010,  12  MILLION  AMERICANS            AGE  12  AND  OLDER  REPORTED            NON-­‐MEDICAL  USE  OF  PRESCRIPTION            PAIN  KILLERS  IN  THE  PAST  YEAR.   •  NEARLY  ½  MILLION  EMERGENCY  DEPARTMENT   VISITS  IN  2009  WERE          DUE  TO  PEOPLE  MIS-­‐USING  OR  ABUSING                  PRESCRIPTION  PAIN  KILLERS.  
  • 16. WHY  ALL  THE  FUSS  ?   •  NON-­‐MEDICAL  USE  OF          PRESCRIPTION  PAIN  KILLERS        COSTS  HEALTH  INSURORS  UP          TO  $72.5  BILLION  ANNUALLY          FOR  DIRECT  HEALTH  CARE.     •   98  OF  THE  TOP  100  DOCTORS            IN  THE  COUNTRY  DISPENSING  OXYCODONE                DO  SO  IN  THE  STATE  OF  FLORIDA.  
  • 18. HOW  DID  WE  GET  HERE  FROM   THERE  ?   •  EVOLVED  INTO  A  SOCIETY  THAT  BELIEVES  WE   ARE  SUPPOSED          TO  FEEL  GOOD  ALL  THE  TIME.   •  PAIN  AND          DISCOMFORT          ARE  BAD.  
  • 19. CHEMICAL  COPING   •  PHYSICIANS        ARE    EXPECTED          TO  ALLEVIATE  ALL                UNPLEASANTNESS.      
  • 20. •  PRESCRIPTION  OPIOIDS  ARE   PLENTIFUL        AND  VERY        INEXPENSIVE.  
  • 21. STREET  PRICES   – 10  MG  HYDROCODONE    …  $6  -­‐  $8.   – OXYCODONE  …  $10  -­‐  $20   – 4  MG  DILAUDID  …  $60   – ADDERALL  …  $1  MG    
  • 22. STREET  PRICES   – BENZODIAZEPINE  $1  -­‐  $2  MG   – RITALIN  $10  -­‐    $20   – SOMA  $3  
  • 23. MOBILITY   •  HIT  2  OR  3  DOCTORS  OFFICES   PLUS  SEVERAL  EMERGENCY   ROOMS  IN  12  HOURS.  
  • 24. A  BEAST  THAT  CAN’T  BE  FED          THERE  IS  A  NEVER        ENDING  NEED          FOR  THE  DRUG.      
  • 25. HOLY  TRINITY   •  HYDROCODONE  IS  EASILY  COMBINED          WITH  OTHER  MOOD-­‐ALTERING  DRUGS.   •  HYDROCODONE,          XANAX  AND  SOMA          ARE  THE  HOLY  TRINITY.      
  • 26. DRUG  OF  CHOICE   ADD  A  LITTLE  BIT  OF  JACK     DANIELS  AND  YOU  HAVE     THE  WHITNEY  HOUSTON  COCKTAIL.      
  • 27. LAW  ENFORCEMENT   •  VERY  DIFFICULT  TO  STAY  ON          TOP  OF  THIS  EPIDEMIC.       •  LAW  ENFORCEMENT  IS  OUT-­‐NUMBERED  AND   OUT-­‐FINANCED.  
  • 28. LAW  ENFORCEMENT   •  DRUG  DEALERS  USUALLY        DO  NOT  SUFFER  FROM          THE  SAME  BUDGET          CONTRAINTS  AS  LAW  ENFORCEMENT.       •  CANNOT  “ARREST  OUR  WAY  OUT  OF  THIS   PROBLEM.”  
  • 29. EPIDEMIC  PROPORTIONS   •  THIS  EPIDEMIC  HAS  ENGULFED  OUR   COUNTRY,  OUR  PRACTICES,  OUR  SOCIETY,   AND        OUR  LIVELIHOODS.      
  • 31. PHYSICIAN  PROFILE   QUESTION:   •  WHAT  TYPE  OF  DOCTOR          PRESCRIBES  EXCESSIVE          AMOUNTS  OF  OPIOIDS?   ANSWER:   •  GOOD  CLINICIAN  
  • 32. PHYSICIAN  PROFILE   •  TYPICALLY,  WELL  TRAINED  PAIN   MANAGEMENT  PHYSICIANS.       •  PROCEDURELESS     •  OFTEN  WRITE        LARGE  VOLUMES  OF  PAIN  MEDICATION.  
  • 33. PHYSICIAN  PROFILE   •  WELL-­‐INTENTIONED  PHYSICIANS  WHO  BELIEVE  PEOPLE  ARE   NOT  SUPPOSED  TO  HURT.       •  DO  NOT  PRACTICE          EVIDENCE  BASED          MEDICINE.       •  WRITE  LARGE          QUANTITIES  OF          OPIOIDS  WITH  REFILLS.    
  • 34. CHEMICAL  COPING   TYPICAL  PRESCRIPTION:   •  LORCET  PLUS  #90  OR  #120     •  ONE  P.O.  T.I.D.  OR  …   •  ONE  P.O.  Q.I.D.  WITH  5  REFILLS.      
  • 35. WHEN  MONEY  DRIVES  MEDICINE   •  CRIMINALS  WITH  A  MEDICAL  DEGEREE  AND   LICENSE  TO  PRACTICE  MEDICINE   •  STATE  BOARD  OF          MEDICAL  LICENSURE   •  SMALL  COHORT        OF  PHYSICIANS  
  • 36. MONITORING  PRESCRIBING  PATTERNS   •  HOW  DO  YOU  IDENTIFY          PHYSICIANS  WHO  WRITE          TOO  MANY  OPIOIDS?  
  • 37. MONITORING  PRESCRIBING  PATTERNS   PHARMACISTS     •  EXCELLENT  SOURCE  OF  INFORMATION.       •  KNOW  WHICH  DOCTORS  HAVE  A  LOOSE  PEN.       •  KNOW  THE  PRESCRIBING  HABITS  OF  EACH  PROVIDER   IN  THEIR  COMMUNITY.      
  • 38. PRESCRIPTION  MONITORING  PROGRAM   •  CAN  BE  RUN  ON  INDIVIDUAL  PATIENTS  AND   INDIVIDUAL  PRESCRIBERS.   •  EXCELLENT  TOOL  FOR  IDENTIFYING  DRUG   SEEKING  PATIENTS  AND  PRESCRIBERS  WHO   WRITE  TOO  MANY  SCHEDULED  DRUGS.      
  • 39. PRESCRIPTION  MONITORING   PROGRAM   DRAWBACKS   – NOT  REAL  TIME   – NOT  INTERSTATE   – LACK  OF  FUNDING  
  • 40. • TAG  CHECK     • ZIP  CODE  CHECK    
  • 41. PHYSICIAN  DRIFT   •  OUT-­‐OF-­‐SPECIALTLY          PHYSICIANS          PRACTICING          IN  PAIN  CLINICS      
  • 42. BUSINESS  OF  MEDICINE   •  PAIN  CLINICS  OWNED  BY  NON-­‐PHYSICIANS  AS   BUSINESS  VENTURES.       •  EMPLOY          PHYSICIANS     •  CASH  ONLY          PILL  MILLS  
  • 43. •  RETIRED  OR  OLDER  PHYSICIAN.       •  LIKES  PRACTICING  MEDICINE  AGAIN.       •  RESIDENTS          WHO  MOONLIGHT.     •  PRESCRIPTIVE          PATTERN  THAT  IS          OUT  OF  THE  ORDINARY  
  • 44. NEW  CME  REQUIREMENT     •  EVERY  LICENSEE     •  40  HOURS          IN  A  2-­‐YEAR  CYCLE     •  5  HOURS  RELATED          TO  “PRESCRIBING          MEDICATIONS”   •  EMPHASIS  ON          CONTROLLED  SUBSTANCES.      
  • 45. THE  SCIENCE  OF  OPOIDS   •  PROVEN  EFFICACY  FOR  USE  OF  OPIOIDS          FOR  SHORT  TERM  NON-­‐CANCER  PAIN.       •  VERY  LITTLE  SCIENTIFIC  EVIDENCE  THAT   LONGTERM  USE  OF  OPIOIDS  FOR  NON-­‐ CANCER  PAIN  IS  EFFECTIVE.      
  • 46. THE  SCIENCE  OF  OPOIDS   •  SIGNIFICANT  EVIDENCE  THAT  LONG  TERM  OPIOID   USE  FOR  NON-­‐CANCER  PAIN  WILL  RESULT  IN  OPIOID          HYPERALYGESIA          SYNDROME.  
  • 47. QUESTIONS  ?   •  ANSWERS  …  $5   •  CORRECT  ANSWERS    …  $10   •  CORRECT  ANSWERS        YOU  CAN  UNDERSTAND    …  $25    
  • 48. TREATING  PAIN   Randy  Easterling,  M.D.   Dan  BarneD,  M.D.,  J.D.   April  2,  2013  
  • 49. Disclosures   Daniel  BarneD  has  no  financial  rela%onships  with  proprietary   en%%es  that  produce  health  care  goods  and  services.  
  • 50. Where  Tennessee  Stands   •  2nd  Most  Medicated  State  (Forbes   Magazine,  August  16,  2010)   •  5th  in  Average  Mg.  Opioids/Resident  (Oct.   2012  Journal  of  Pain)  
  • 51. Controlled  Substances  in  Tennessee   •  Just  over  18  million  prescrip%ons  for   controlled  substances  dispensed  in  2012.   •  Increase  of  1.5  %  from  2011  (compared  to  a   23%  rise  from  2010  –  2011).   •  Increased  use  of  TN  Controlled  Substance   Database/State  Registra%on  of  Pain  Clinics.  
  • 53. Issue:  How  to  Control  the  Source  of   Controlled  Substances?   •  Solu%on:    Oversight  of  the  Prescribing   Physicians.   •  But  How?  
  • 54. Physicians   1.  Highly  Educated   2.  Lengthy  Training   3.  Ongoing  CME  Requirements   4.  Independent  
  • 55. PEER  REVIEW   •  Other  Physicians  Reviewing  the  Records   and  Management  of  Physicians  with   Possible  Quality  Problems   •  Used  in  Hospitals  for  years   •  Why  not  in  Health  Plans?  
  • 56. PLANS  ARE  IN  A  GOOD  POSITION  TO   ASSESS  QUALITY  OF  CARE  OF  NETWORK   PROVIDERS   •  We  pay  claims  (and  have  claims  data).   •  We  have  audit  rights  in  provider  contracts.   •  We  review  medical  records.   •  We  are  in  providers’  offices.   •  No  “compe%tors  out  to  get  me”  in  Plan  peer  review.  
  • 58. The  BCBST  CRM  Program  Reviews  All   Quality  of  Care  Complaints  and  Concerns   •  Required  to  review  member  complaints   by  accredi%ng  agencies  (NCQA,  URAC)   and  state  Medicaid  program.   •  Liability/Risk  reduc%on  method.  
  • 59. The  BCBST  CRM  Program  is  staffed  by   clinical  professionals   •  4  RNs  review  cases.   •  Support  from  BCBST  Pharmacy  Department   staffed  by  12  Pharmacists.   •  Support  from  Analy%cs  Area  to  Review   Prescribing  Data.  
  • 60. How  Do  We  Get  RX  Cases?   •  Referrals  from  Pharmacy  Department.   •  Pharmacists  iden%fy  outliers  in  their  areas  of   responsibility  and  contact  the  providers  to  try   to  determine  why  they  are  outliers.   •  If  no  explana%on  and  no  change  in  prac%ce   aser  contact,  refer  to  CRM.  
  • 61. Also  from  Member  Complaints          Mbr  wants  complaint  filed  against  provider   (prv).  On  one  visit,  mbr  didn’t  want  his  shot  b/c   they  were  administering  it  where  it  was  making   mbr's  back  swell  up.  Aser  he  declined  the  shot,   the  prv  ripped  up  his  rx  for  Valium.  Once  the  rx   was  ripped  up,  mbr  had  no  choice  but  to  take   the  shot.  Then  aser  they  gave  him  the  shot,   they  rewrote  his  rx  for  Valium.  Per  mbr,  it  was   as  if  prv  was  blackmailing  him:  if  he  didn’t  take   the  shot,  they  wouldn’t  write  his  rx.    
  • 62. The  CRM  Process   1.  Obtain  medical  records  from  dates  of  service   when  pain  meds.  prescribed.   2.  Review  medical  records  internally.   3.  Refer  suspect  records  for  specialty  matched   review  (through  Independent  Review   Organiza%ons).  
  • 63. Standard  of  Care   That  level  of  care  below  which  no     reasonable  medical  provider  would    prac%ce.  
  • 64. Medical  Correc%ve  Ac%on  Plan   •  Specialty  matched  review  shows   standard  of  care  not  met  for  controlled   substance  prescribing.   •  LeDer  with  reviewer’s  comments  giving   examples  of  why  standard  not  met.   •  Provider  advised  to  take  whatever  steps   are  necessary  to  correct  prac%ce.  
  • 65. Model  Policy  for  the  Use  of  Controlled   Substances  for  the  Treatment  of  Pain   Medical  Records  –  The  physician  should  keep  accurate  and  complete  records  to  include:   1.  the  medical  history  and  physical  examina%on,   2.  diagnos%c,  therapeu%c  and  laboratory  results,   3.  evalua%ons  and  consulta%ons,     4.  treatment  objec%ves,   5.  decision  of  risks  and  benefits,     6.  informed  consent,     7.  treatments,   8.  medica%ons  (including  date,  type,  dosage  and  quan%ty  prescribed),   9.  instruc%ons  and  agreements  and   10.  periodic  reviews.   Records  should  remain  current  and  be  maintained  in  an  accessible     manner  and  readily  available  for  review.  
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71. Reasons  for  MCAP  Failure   1.         Lack  of  Provider  Knowledge   2.  TIME    =    MONEY  
  • 72. Consequences  of  MCAP  Failure   1.  Creden%aling  CommiDee  –  Creden%als   Revoked.   2.  Formal  Hearing  –  Due  Process   3.  Report  Filed  with  Healthcare  Integrity   and  Protec%on  Data  Bank  (HIPDB)  
  • 73. QUESTIONS   ?